Dr. Deveau, named “Dr. D” by her students, is an energetic professor who primarily teaches organic chemistry. She also teaches courses in general chemistry, medicinal chemistry, and NMR spectroscopy. Dr. D is passionate about undergraduate education and mentoring students in research, serving as a Chemistry Councilor for the Council of Undergraduate Research. Also a member of UNE’s Center for Excellence in the Neurosciences, Dr. D’s laboratory focuses on the discovery of organic small molecules with therapeutic potential, across the areas of pain & addiction and anti-infectives. Mining local seaweeds as a source of novel marine natural products is also an emerging area of research in her lab.
University of Vermont (Burlington, Vermont)
Dr. Deveau presently has three ongoing research projects in her laboratory: (1) the design and semisynthesis of novel opioid derivatives for the treatment of pain and addiction; (2) the design and synthesis of novel DNA intercalators; (3) the development of greener methods for organic synthesis and their pedagogical application.
Andrea L. Pelotte, Ryan M. Smith, Mario Ayestas, Christina M. Dersch, Edward J. Bilsky, Richard B. Rothman, Amy M. Deveau. Design, Synthesis, and Characterization of 6_-Naltrexol Analogs, and Their Selectivity for In Vitro Opioid Receptor Subtypes. Bioorganic & Medicinal Chemistry Letters, 2009, 19, 2811-2814.
Amy M. Deveau, Nancy E. Costa, Elizabeth M. Joshi, Timothy L. Macdonald. Synthesis of Carboline Homodimers, and Evaluation in In Vitro Carcinoma Lines. Bioorganic and Medicinal Chemistry Letters 2008, 18, 12, 3522-3525.
H.D. Jain, C. Zhang, S. Zhou, H. Zhou, J. Ma, X. Liu, X. Liao, Amy M. Deveau, Christine M. Dieckhaus, Michael A. Johnson, Kirsten S. Smith, Timothy L. Macdonald, H. Kakeya, H. Osada and James M. Cook. Synthesis and structure_activity relationship studies on tryprostatin A, a potent inhibitor of breast cancer resistance protein. Bioorganic & Medicinal Chemistry 2008, 16, 4626-4651.